Lactulose

CAS 4618-18-2 8 current records 2 historicalSmall Molecule

Who holds supplier records for Lactulose? 8 organisations hold a current record for Lactulose: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: France (1), China (1), Denmark (1), Austria (1) and 4 other countries (4).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Lactulose: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lactulose

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lactulose. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Lactulose sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Lactulose, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
LACTOSE (INDIA) LIMITED MumbaiIN
CEP 2025-451 - Rev 00
Lactulose, liquid, 620 g/l
Apr 2026—
Fresenius Kabi Austria GmbH LinzAT
CEP 2019-138 - Rev 01
Lactulose, liquid, 667 g/L
Aug 2024Inspected May 2025
Austria
ABBOTT LABORATORIES CO. VictoriavilleCA
R1-CEP 2005-102 - Rev 05
Lactulose, liquid, 634 g/l to 700 g/l
Feb 2020—
RELAX LIMITED LuqaMT
R1-CEP 1999-168 - Rev 03
Lactulose, liquid, 660 g/l, 700 g/l
Aug 2014—
Danipharm A/S KastrupDK
R1-CEP 2002-162 - Rev 02
Lactulose, liquid, 620 g/l to 700 g/l
Nov 2013—
ABBOTT HEALTHCARE PRODUCTS B.V. WeespNL
R1-CEP 1997-060 - Rev 04
Lactulose, liquid, 667g/l
Jun 2010—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Lactulose are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • SOLVAY DUPHAR BV
    Inactive DMF 12699 · filed Oct 1997
  • Italy · Inactive DMF 7833 · filed Dec 1988

Overview

Lactulose is a non-digestible synthetic disaccharide used as a laxative to treat constipation and hepatic encephalopathy. It works by increasing the number of bowel movements per day and the number of days of bowel movements.

Chemical identity

IUPAC name
(3S,4R,5R)-1,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-one
Canonical SMILES
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H](C(=O)CO)O)O)O)O)O
InChIKey
PFCRQPBOOFTZGQ-VZXVHDRGSA-N
Synonyms
Enulose API, 4-galactosyl fructose, acilac, cephulac, cholac, chronulac, constilac, constulose, duphalac, enulose, evalose, generlac

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Osmotic Laxative
Mechanism of action
Acidifying Activity; Osmotic Activity
Physiologic effect
Stimulation Large Intestine Fluid/Electrolyte Secretion

Therapeutic areas

GastroenterologyHepatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lactulose?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Lactulose: API PHARMA TECH LLC (France), SYNGARS TECHNOLOGY CO LTD (China), Danipharm A/S (Denmark), FRESENIUS KABI AUSTRIA GMBH (Austria), LACTOSE (INDIA) LTD (India), RELAX LTD (Malta), ABBOTT LABORATORIES CO. Victoriaville (Canada) and ABBOTT HEALTHCARE PRODUCTS B.V. (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lactulose Drug Master Files are active?

API PHARMA TECH LLC (DMF 42605) and SYNGARS TECHNOLOGY CO LTD (DMF 38252). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Lactulose records mean?

2 organisations have only inactive Type II DMFs for Lactulose. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Lactulose have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Lactulose on the EDQM register, including LACTOSE (INDIA) LIMITED Mumbai (IN), Fresenius Kabi Austria GmbH Linz (AT), ABBOTT LABORATORIES CO. Victoriaville (CA), RELAX LIMITED Luqa (MT), Danipharm A/S Kastrup (DK) and ABBOTT HEALTHCARE PRODUCTS B.V. Weesp (NL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Lactulose supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lactulose?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.